Anhui Huaheng Biotechnology Co., Ltd.

688639

CNE1000052M6

Food Processing

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
118.4 ^CNY	+1.07%		+12.89%	-5.94%

Apr. 22	Anhui Huaheng Biotechnology's Q1 Profit Jumps 7%	MT
Apr. 22	Anhui Huaheng Biotechnology's 2023 Profit Jumps 40%	MT

Wuhan Ruijiakang Biotechnology Co., Ltd. announced that it has received CNY 20 million in funding from Anhui Huaheng Biotechnology Co., Ltd., Suzhou Kaifeng Zhengde Investment Management Co., Ltd.

August 20, 2023

Wuhan Ruijiakang Biotechnology Co., Ltd. announced that it has raised CNY 20 million in a round of funding on August 21, 2023. The transaction included participation from new investors, Anhui Huaheng Biotechnology Co., Ltd. and Suzhou Kaifeng Zhengde Investment Management Co., Ltd.

Latest news about Anhui Huaheng Biotechnology Co., Ltd.

Anhui Huaheng Biotechnology's Q1 Profit Jumps 7%	Apr. 22	MT
Anhui Huaheng Biotechnology's 2023 Profit Jumps 40%	Apr. 22	MT
Certain A Shares of Anhui Huaheng Biotechnology Co., Ltd. are subject to a Lock-Up Agreement Ending on 22-APR-2024.	Apr. 21	CI
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 21	CI
Rate Cut Plans Boost China Stocks; Huaheng Biotechnology Jumps 9%	Mar. 08	MT
Huaheng Biotechnology to Set Up Subsidiary, Production Plant for 700 Million Yuan	Mar. 07	MT
Huaheng Biotechnology Gets Rights to Ouhe Biotechnology's Biological Arginine Production Technology	Mar. 07	MT
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 23	CI
Tranche Update on Anhui Huaheng Biotechnology Co., Ltd.'s Equity Buyback Plan announced on August 11, 2023.	Feb. 08	CI
Anhui Huaheng Biotechnology Co., Ltd.'s Equity Buyback announced on August 11, 2023, has closed with 496,600 shares, representing 0.32% for CNY 49.98 million.	Feb. 07	CI
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Tranche Update on Anhui Huaheng Biotechnology Co., Ltd.'s Equity Buyback Plan announced on August 11, 2023.	23-10-09	CI
Anhui Huaheng Biotechnology Co., Ltd.(XSSC:688639) added to S&P Global BMI Index	23-09-18	CI
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Wuhan Ruijiakang Biotechnology Co., Ltd. announced that it has received CNY 20 million in funding from Anhui Huaheng Biotechnology Co., Ltd., Suzhou Kaifeng Zhengde Investment Management Co., Ltd.	23-08-20	CI
Anhui Huaheng Biotechnology Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.	23-08-11	CI
Anhui Huaheng Biotechnology Co., Ltd. authorizes a Buyback Plan.	23-08-10	CI
Anhui Huaheng Biotechnology Acquires Marketing Rights to Ouhe Biotechnology's Phytic Acid Technology	23-04-26	MT
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Huaheng Biotechnology Unit Earmarks 400 Million Yuan for Mongolia Plant	22-12-08	MT
Anhui Huaheng Biotechnology Co., Ltd. announces decision of Shareholder/Board on the transaction	22-11-14	CI
Anhui Huaheng Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Anhui Huaheng Biotechnology Co., Ltd. announced that it expects to receive CNY 1.7270709 billion in funding	22-10-26	CI
Tianjin Zhihe Biotechnology Co., Ltd. announced that it expects to receive CNY 10 million in funding from Anhui Huaheng Biotechnology Co., Ltd.	22-09-12	CI

Chart Anhui Huaheng Biotechnology Co., Ltd.

Duration

Period

Chart Anhui Huaheng Biotechnology Co., Ltd.

More charts

Company Profile

Anhui Huaheng Biotechnology Co Ltd is a China-based company specializing in the research and development, production and sales of amino acids and other bio-based products based on alanine series products. The Company is a high-tech enterprise focusing on synthetic biotechnology and mainly engaged in the research and development, production and sales of amino acid and its derivative products. The Company's main products include alanine series products (L-alanine, DL-alanine, Î²-alanine), calcium D-pantothenate and Î±-arbutin. The Company's products are mainly used in the fields of medicine and health products, daily chemicals, food and food additives. The Company distributes its products and services within the domestic market and to overseas markets.

Sector

Food Processing

Calendar

2024-08-14 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Anhui Huaheng Biotechnology Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

118.4 CNY

Average target price

135.7 CNY

Spread / Average Target

+14.61%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Food Ingredients

	1st Jan change	Capi.
ANHUI HUAHENG BIOTECHNOLOGY CO., LTD.	-5.94%	2.57B
FOSHAN HAITIAN FLAVOURING AND FOOD COMPANY LTD.	+3.45%	30.12B
INTERNATIONAL FLAVORS & FRAGRANCES INC.	+7.21%	21.44B
KIKKOMAN CORPORATION	+10.44%	11.49B
LANCASTER COLONY CORPORATION	+15.39%	5.27B
MEIHUA HOLDINGS GROUP CO.,LTD	+16.44%	4.38B
ANGEL YEAST CO., LTD	-15.24%	3.53B
TATE & LYLE PLC	-0.53%	3.24B
JONJEE HI-TECH INDUSTRIAL AND COMMERCIAL HOLDING CO.,LTD	+4.98%	3.12B
KEWPIE CORPORATION	+28.84%	2.81B

Food Ingredients

Anhui Huaheng Biotechnology Co., Ltd.

Equities

688639

CNE1000052M6

Food Processing

Wuhan Ruijiakang Biotechnology Co., Ltd. announced that it has received CNY 20 million in funding from Anhui Huaheng Biotechnology Co., Ltd., Suzhou Kaifeng Zhengde Investment Management Co., Ltd.

EPS Revisions